Abstract
The beta(-) emitter, rhenium-188 (Re-188), has long been recognized as an attractive candidate for targeted cancer radionuclide therapy (TRNT). This t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
